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The year 2013 brought major modifications in ESCMID's publications. In fact, a new journal from the ESCMID has been created; it is called New Microbes and New Infections, and its Editor-in-Chief is Michel Drancourt, formerly associate editor of CMI. The reason for the creation of this journal was related to two factors: on the one hand, the increase in rejections of high quality submissions to CMI raised the question of a loss of ability to publish high-quality papers; on the other hand, work by Evelina Tacconelli on mismatches for acceptance rates for papers from emerging countries led to editorial reflection with a themed section (Infection problems in South-East Europe and neighbours. Clin Microbiol Infect 2012; 18: 1053-1156), and partly a discussion in the journal on this particular problem [1] .
The solution to this problem was the creation of a new journal that can directly receive from CMI items better suited to its objective, which is the description of emerging pathogens in countries where they were previously unknown. This allows rapid publication and the first issue has now been published. The new journal is managed by Michel Drancourt, which led him to leave his position as associate editor of CMI; he has been replaced by Mical Paul, who invests heavily in the assessment of papers on research in infectious diseases. Therefore, Evelina Tacconelli agreed to be associate editor instead of Mical Paul and complete our team.
The various topics covered by CMI are shown in Fig. 1 , and show a reasonable balance between the different sections included in the journal. Themed sections attract attention to the priorities of infectious disease physicians-they are a real specificity of the journal. The rates of acceptance and rejection are now stable, with an acceptance rate of approximately 20% for original publications and research.
Finally, regarding the most cited articles, we see a significant change in the journal, as the scope of CMI has changed over the last 3 years, and this strategy is reflected in the most cited articles (Table 8) . Thus, among the most cited articles, four concern virology, which was not previously in the spectrum of the journal, three concern mycology, five concern antibiotics, one concerns tropical pathology with leishmaniasis, and four concern matrix-assisted laser desorption ionization time-of--flight mass spectrometry, which is a new technology that has stimulated many citations.
The Journal's Editorial Structure CMI appears monthly, and includes peer-reviewed manuscripts, reviews and research notes. Each print and online issue includes a themed section. These are organized by a guest editor, and cover key topics. They consist of three to five invited reviews on the chosen topic, an editorial, and related cover images. Table 2 shows all of the themed sections published in 2013 and those scheduled for 2014.
Submissions
The proportion of manuscripts submitted as original articles or as research notes (separate from invited reviews and editorials) is continuously increasing. Also, these manuscripts come from a large variety of countries (Table 3) ; this shows that the journal is sought by many authors in various countries, even though acceptance rates are not currently equivalent for all countries. As compared with 2011, it is interesting to note that new countries, such as Madagascar, have managed to publish for the first time in CMI. This clearly confirms the willingness of the journal to be open to the world, including emerging countries. It is also interesting to note that China and Taiwan are among the top ten countries submitting papers to CMI. The journal continues to make efforts to help improve papers coming from countries with cultural and organizational difficulties, with high scientific quality, allowing them to reach a standard that is more consistent with the community's standards.
Citations and Readership
CMI achieved some excellent results in the latest Journal Citation Reports â . The headline 2-year impact factor increased by 0.8% to 4.578, and the 5-year impact factor (which concerned citations in 2012 of items published in the previous 5 years) showed an even greater increase, of 8.1%. The journal's immediacy index increased by over 25% for 2012. This measures citations in 2012 of papers published in 2012 (rather than in the previous 2 years), and so indicates that CMI is publishing highly topical material that is being cited very soon after publication. CMI also achieved significant increases in its Eigen factor (up 11%) and article influence score (up 8.2%), both of which are strong indicators of the journal's prestige within the scientific community.
As can be seen in Fig. 2 , CMI's impact factor has grown substantially over the last decade, and remains well above the aggregate and median levels for both of its subject categories. The journal is currently ranked 11 of 69 journals in infectious diseases, and 22 of 116 in microbiology. 34 The article that made the greatest contribution to the 2012 impact factor was 'Evolving epidemiology of hepatitis C virus' by D. Lavanchy [7] , with more than 50 citations in 2012 alone.
Fourteen other articles published in the two survey years achieved 20 or more citations in 2012.
Readership
As with citations, readership is another success story for CMI. In the last full year (2012), total full-text downloads increased by more than 30% on the prior year, to exceed 800,000. Early figures for 2013 suggest that this total will increase again.
At the time of writing, the most downloaded article in 2013 was 'Mesh-related infections after hernia repair surgery' by Falagas and Kasiakou [1] , followed by 'Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance' by Magiorakos et al. [2] . New publications and older articles are both strongly represented among the top 50 most read.
Online Publications and Backlog Management
The number of submitted papers has not diminished; therefore, the number of quality papers that we want to publish is increasing, and, despite the increased online-only page budget, the large volume of articles makes it difficult for the time to publication in an issue to decrease. However, the time to Early View publication has decreased to 48 days, down from 55 days in 2012. We consider that Early View publication is essentially no different from final publication, as the article is fully citable and searchable in PubMed.
Infection Hot Topics
From the start, this category has provided an immediate platform for the entire editorial board, and is thus closer to the discussions of the scientific community. This selection has been a real success from the time of its establishment.
The Position of the Journal within International Competition
CMI is going from strength to strength, achieving an impact factor of 4.578 in the latest ISI Journal Citations Report, ranking the journal at number 11 in the ISI infectious diseases subject category. In 2012, CMI articles were downloaded 
Future Evolution and Perspectives
For the next 2 years, we want to stabilize the current size of the journal, in order to assess its real impact in the scientific community. The journal will continue to have a themed section per issue, as well as approximately ten original articles, on top of which Research Notes and longer articles will be available online. The journal also publishes supplementary issues ( 
The Journal's Most Cited Articles
The articles in Table 8 made the greatest contribution to the 2012 impact factor, i.e. articles published in 2010 and 2011 that received the most citations in 2012.
Workflow-Evolution Since 2009
The current processing time for manuscripts has continued to improve since 2009 (Table 9 ). In 2012, this averaged 29 days; this is broken down into 7 days for immediate rejection, and 44 days for a decision of acceptance, revision or rejection after peer-review, which, at present, appears reasonable.
The average time between final acceptance and the first online publication is 1 week for the accepted manuscript as supplied by the author, and 7 weeks for the version copy-edited and typeset by the publisher. For articles published this year, the average time to publication in an issue is 4.25 months. The aim remains for the print version to be available within 3-4 months after final acceptance. After an average processing time of 4.5 months between acceptance and final publication over the last five, this objective is currently being achieved.
Conclusion
The ambition of CMI is to reflect the academic activities of the ESCMID, and more generally of the world of infectious diseases and clinical microbiology, as well as to attract the best publications and reviews within the field. It also aims to attract attention to emerging fields or questions based on the focus provided by themed sections.
